Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli

Singapore Med J. 2007 Jun;48(6):600-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Cefepime
  • Cephalosporins / therapeutic use*
  • Drug Resistance, Multiple, Bacterial
  • Escherichia coli / drug effects
  • Escherichia coli Infections / drug therapy*
  • Hospitals, Urban
  • Humans
  • India
  • Intensive Care Units
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae / drug effects
  • Meropenem
  • Microbial Sensitivity Tests
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / therapeutic use
  • Piperacillin / therapeutic use
  • Piperacillin, Tazobactam Drug Combination
  • Sepsis / drug therapy
  • Thienamycins / therapeutic use
  • beta-Lactamases / analysis
  • beta-Lactamases / drug effects*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Thienamycins
  • Piperacillin, Tazobactam Drug Combination
  • Cefepime
  • Penicillanic Acid
  • beta-Lactamases
  • Meropenem
  • Piperacillin